Use of 2-hydroxy or 2-acetyloxy-4-trifluoromethylbenzoic acid derivatives as an agent for the treatment and prevention of mild cognitive impairment
CA 2471794 A1 · Owner: Munoz Orti, Genis · Inventors: Izquierdo Pulido, Jose Ignacio; Navas Ramirez, Jose Carlos; Garcia-Rafanell, Julian
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the use of 2-hydroxy or 2-acetyloxy-4trifluoromethylbenzoic acid, respectively for the treatment or prevention of , mild cognitive impairment (MCI) in mammals especially in human beings. , Futhermore the present invention also concerns the use of 2-hydroxy or 2acetyloxy-4-trifluoromethylbenzoic acid respectively, for delaying or , preventing the conversion of MCI into dementia especially Alzheimer's Disease.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 6, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 6, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 6, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.